Weight-Loss Surgery Benefits Blood Pressure Management
By Lori Solomon HealthDay Reporter
TUESDAY, Sept. 10, 2024 -- Bariatric surgery emerges as a durable solution for obesity-related hypertension, according to a study presented at the American Heart Association Hypertension Scientific Sessions 2024, held from Sept. 5 to 8 in Chicago.
Sneha Annie Sebastian, M.D., from Azeezia Medical College in Kerala, India, and a residency candidate from Alberta, Canada, and colleagues synthesized findings from 18 pivotal randomized controlled trials (1,386 patients with obesity) to evaluate the long-term effects of bariatric surgery on hypertension in individuals with obesity compared to medical or lifestyle management.
The researchers found that in a pooled analysis, there was a statistically significant difference in the rate of hypertension remission between patients who underwent bariatric surgery versus patients on medical or lifestyle management (risk ratio [RR], 2.77; 95 percent confidence interval [CI], 1.26 to 6.10). Relatedly, there was a substantial reduction in the use of antihypertensive medications while maintaining controlled blood pressure (RR, 7.10; 95 percent CI, 4.38 to 11.51), with no heterogeneity among findings. There were also significant improvements in systolic blood pressure control associated with bariatric surgery.
"Bariatric surgery is an effective solution for managing obesity-related hypertension," Sebastian said in a statement. "Future research should focus on conducting randomized controlled trials with long-term follow-up and large sample sizes, with a specific emphasis on hypertension outcomes, as many currently focus on diabetes outcomes."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
GLP-1 Receptor Agonists May Improve Outcomes in Idiopathic Intracranial Hypertension
MONDAY, July 21, 2025 -- For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is associated with improved...
ENDO: Primary Aldosteronism Screening Recommended for All With Hypertension
FRIDAY, July 18, 2025 -- All individuals with hypertension should be screened for primary aldosteronism (PA), according to a clinical practice guideline issued by the Endocrine...
Delays in HTN Diagnosis Linked to Delays in Medication Prescribing
THURSDAY, July 17, 2025 -- Delays in diagnosis of hypertension are common and associated with delays in treatment initiation, according to a study published online July 14 in JAMA...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.